Annual Non Current Assets
$4.73 M
+$3.48 M+276.67%
December 31, 2023
Summary
- As of February 7, 2025, ESPR annual long term assets is $4.73 million, with the most recent change of +$3.48 million (+276.67%) on December 31, 2023.
- During the last 3 years, ESPR annual non current assets has fallen by -$2.63 million (-35.74%).
- ESPR annual non current assets is now -94.17% below its all-time high of $81.18 million, reached on December 31, 2015.
Performance
ESPR Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$6.56 M
-$652.00 K-9.04%
September 30, 2024
Summary
- As of February 7, 2025, ESPR quarterly long term assets is $6.56 million, with the most recent change of -$652.00 thousand (-9.04%) on September 30, 2024.
- Over the past year, ESPR quarterly non current assets has dropped by -$652.00 thousand (-9.04%).
- ESPR quarterly non current assets is now -93.83% below its all-time high of $106.27 million, reached on September 30, 2017.
Performance
ESPR Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
ESPR Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +276.7% | -9.0% |
| 3 y3 years | -35.7% | -9.0% |
| 5 y5 years | +477.7% | +262.4% |
ESPR Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -91.0% | +276.7% | -87.5% | +440.3% |
| 5 y | 5-year | -91.0% | +276.7% | -88.0% | +440.3% |
| alltime | all time | -94.2% | +2619.0% | -93.8% | +4525.5% |
Esperion Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.56 M(-9.0%) |
| Jun 2024 | - | $7.21 M(-3.3%) |
| Mar 2024 | - | $7.45 M(+57.6%) |
| Dec 2023 | $201.06 M(-18.5%) | $4.73 M(+53.7%) |
| Sep 2023 | - | $3.08 M(+23.1%) |
| Jun 2023 | - | $2.50 M(+106.0%) |
| Mar 2023 | - | $1.21 M(-3.3%) |
| Dec 2022 | $246.68 M(-25.0%) | $1.26 M(-97.5%) |
| Sep 2022 | - | $51.04 M(-0.9%) |
| Jun 2022 | - | $51.50 M(-1.0%) |
| Mar 2022 | - | $52.03 M(-1.1%) |
| Dec 2021 | $328.97 M(-4.9%) | $52.62 M(-3.6%) |
| Sep 2021 | - | $54.59 M(+932.5%) |
| Jun 2021 | - | $5.29 M(-12.3%) |
| Mar 2021 | - | $6.03 M(-18.1%) |
| Dec 2020 | $345.90 M(+63.4%) | $7.36 M(-9.8%) |
| Sep 2020 | - | $8.17 M(-9.1%) |
| Jun 2020 | - | $8.98 M(+28.1%) |
| Mar 2020 | - | $7.01 M(+156.6%) |
| Dec 2019 | $211.71 M(+48.4%) | $2.73 M(+51.0%) |
| Sep 2019 | - | $1.81 M(+6.9%) |
| Jun 2019 | - | $1.69 M(+34.3%) |
| Mar 2019 | - | $1.26 M(+54.0%) |
| Dec 2018 | $142.63 M | $819.00 K(-85.9%) |
| Sep 2018 | - | $5.82 M(-73.5%) |
| Jun 2018 | - | $22.00 M(-48.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $42.78 M(-42.1%) |
| Dec 2017 | $203.92 M(-4.5%) | $73.91 M(-30.4%) |
| Sep 2017 | - | $106.27 M(+643.5%) |
| Jun 2017 | - | $14.29 M(-46.3%) |
| Mar 2017 | - | $26.60 M(-15.9%) |
| Dec 2016 | $213.58 M(-0.4%) | $31.64 M(-37.1%) |
| Sep 2016 | - | $50.32 M(-26.4%) |
| Jun 2016 | - | $68.38 M(-23.2%) |
| Mar 2016 | - | $88.98 M(+9.6%) |
| Dec 2015 | $214.39 M(+100.9%) | $81.18 M(-7.3%) |
| Sep 2015 | - | $87.55 M(-3.0%) |
| Jun 2015 | - | $90.25 M(+98.8%) |
| Mar 2015 | - | $45.40 M(+24.1%) |
| Dec 2014 | $106.70 M(+76.0%) | $36.58 M(+514.6%) |
| Sep 2014 | - | $5.95 M(-25.3%) |
| Jun 2014 | - | $7.97 M(-33.3%) |
| Mar 2014 | - | $11.94 M(-32.4%) |
| Dec 2013 | $60.62 M(+749.2%) | $17.67 M(+29.8%) |
| Sep 2013 | - | $13.61 M(+9287.4%) |
| Jun 2013 | - | $145.00 K(+2.3%) |
| Mar 2013 | - | $141.80 K(-18.5%) |
| Dec 2012 | $7.14 M(+283.0%) | $174.00 K |
| Dec 2011 | $1.86 M(-95.9%) | - |
| Dec 2002 | $45.26 M(-36.5%) | - |
| Dec 2001 | $71.29 M(-0.1%) | - |
| Dec 2000 | $71.34 M(+1080.5%) | - |
| Dec 1999 | $6.04 M | - |
FAQ
- What is Esperion Therapeutics annual long term assets?
- What is the all time high annual non current assets for Esperion Therapeutics?
- What is Esperion Therapeutics annual non current assets year-on-year change?
- What is Esperion Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly non current assets year-on-year change?
What is Esperion Therapeutics annual long term assets?
The current annual non current assets of ESPR is $4.73 M
What is the all time high annual non current assets for Esperion Therapeutics?
Esperion Therapeutics all-time high annual long term assets is $81.18 M
What is Esperion Therapeutics annual non current assets year-on-year change?
Over the past year, ESPR annual long term assets has changed by +$3.48 M (+276.67%)
What is Esperion Therapeutics quarterly long term assets?
The current quarterly non current assets of ESPR is $6.56 M
What is the all time high quarterly non current assets for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly long term assets is $106.27 M
What is Esperion Therapeutics quarterly non current assets year-on-year change?
Over the past year, ESPR quarterly long term assets has changed by -$652.00 K (-9.04%)